News
The exact cause of AVMs is not known. Experts believe that they can result from developmental errors that occur during ...
Substance abuse in India is a symptom of a larger mental health crisis Find out the root causes statistics and potential ...
John Mascarenhas, MD, discusses phase 1 data showing that INCA33989 is a well-tolerated therapy for calreticulin–mutant essential thrombocythemia, with early signs of efficacy and potential disease ...
Dr Ray O’Connor takes a look at the latest clinical articles on inflammatory bowel disease ...
The STAAR trial showed that a one-shot dose of ST-920 – now known as isaralgagene civaparvovec – was able to improve kidney ...
Recessive dystrophic epidermolysis bullosa (RDEB) is a systemic disease of poor mucocutaneous basement membrane integrity downstream of bi-allelic pathogenic variants in COL7A1. Cutaneous clinical ...
Face yoga has gained online popularity in recent years for its promised antiaging, face slimming effects, but does it ...
2don MSN
New guidelines, developed and led by experts at the University of Nottingham, will help clinicians to better treat the ...
An international study has shown that a drug called selumetinib can reduce the pain and size of tumors caused in adults by ...
14h
Stockhead on MSNHealth Check: Paradigm makes scenic acquisitive detour, but it’s no strategic shiftOsteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.
Detailed price information for Thiogenesis Therapeutics Corp (TTI-X) from The Globe and Mail including charting and trades.
New guidelines published today, developed and led by experts at the University of Nottingham, will help clinicians to better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results